|
10 Years of Enzyme Replacement Therapy
|
IPA |
|
NeoGAA Phase 3 Trial Begins
|
Genzyme |
|
BioMarin Update for the Pompe Community
|
Biomarin |
|
IPA Statement on Biomarin's June 9th announcement it will seek to out-license BMN-701
|
Tiffany |
|
The Walker Society – a beneficiary research fund in honour of Helen Walker
|
Bruce Walker, brother of Helen Walker |
|
Sanofi Genzyme Presents Results from Phase 1/2 Study of Investigational Second-Generation Therapy for Pompe Disease
|
Genzyme |
|
BioMarin Announces Interim Analysis of INSPIRE Clinical Trial in Pompe Disease at 34th Annual J.P. Morgan Annual Healthcare Conference
|
Biomarin |
|
Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease
|
Amicus |
|
The Swiss Pompe Group
|
Caspar Kemper |
|
Pompe Registry - A Decade of Making a Difference
|
Webmaster |
